1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Betamethasone (valerate, dipropionate, sodium phosphate, acetate) |
| brand | String | Celestone (oral/injectable), Diprolene/Diprosone (topical), Luxiq (foam), Celestone Soluspan (depot IM) |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Corticosteroids|Corticosteroid]] • [[:Category:Glucocorticoids|Glucocorticoid (long-acting • high-potency)]] • [[:Category:Topical_corticosteroids|Topical corticosteroid (high-to-super-high potency depending on ester)]] |
| mechanism | String | '"`UNIQ--vote-00001014-QINU`"' Activates the glucocorticoid receptor to broadly remodel inflammatory, immune, and metabolic transcription. The dipropionate, valerate, and augmented dipropionate ester forms determine topical potency (high to super-high)'"`UNIQ--ref-00001015-QINU`"'. |
| uses | String | '"`UNIQ--vote-00001016-QINU`"', '"`UNIQ--vote-00001017-QINU`"', '"`UNIQ--vote-00001018-QINU`"', '"`UNIQ--vote-00001019-QINU`"' |
| starting_dose | String | Antenatal: Celestone Soluspan 12 mg IM q24h × 2 doses; topical: pea-sized amount BID; intra-articular varies by joint |
| preparations | String | 0.6 mg/5 mL oral solution; Celestone Soluspan 6 mg/mL IM/IA (mix of sodium phosphate + acetate); 0.05% and 0.1% topical cream/ointment/lotion/foam (various salts); augmented betamethasone 0.05% (super-high potency) |
| fda_max | String | Indication-specific |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral • IM • IA • topical |
| onset | String | Hours |
| duration | String | Biologic 36-54 hours (long-acting) |
| halflife | String | Plasma ~5 hours; biologic ~36-54 hours'"`UNIQ--ref-0000101A-QINU`"' |
| bioavailability | String | Oral ~70%; depot IM provides sustained release over weeks'"`UNIQ--ref-0000101B-QINU`"' |
| pregnancy | String | |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |
